Those who developed KSD demonstrated several significant differences compared to those who did not, including higher age, higher systolic and diastolic blood pressure, higher incidence of dyslipidemia, BMI, uric acid, hemoglobin, creatinine, BUN, triglyceride, ALT, and lower eGFR level (P < 0.05). This evidence concerns the gene GPT and metabolic syndrome.